Danone (OTCMKTS:DANOY) Shares Cross Below Fifty Day Moving Average – Should You Sell?

Danone (OTCMKTS:DANOYGet Free Report)’s stock price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $15.16 and traded as low as $14.94. Danone shares last traded at $15.07, with a volume of 292,889 shares changing hands.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Morgan Stanley restated an “overweight” rating on shares of Danone in a research report on Monday, February 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Danone in a report on Thursday, May 7th. Finally, Santander raised Danone to an “outperform” rating in a report on Wednesday, June 10th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

View Our Latest Research Report on DANOY

Danone Stock Performance

The business’s 50 day moving average is $15.14 and its two-hundred day moving average is $16.30. The company has a current ratio of 0.90, a quick ratio of 0.75 and a debt-to-equity ratio of 0.58.

About Danone

(Get Free Report)

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.

Read More

Receive News & Ratings for Danone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danone and related companies with MarketBeat.com's FREE daily email newsletter.